Events

All members have the option of attending our various HTC-centric events which include:

  • Spring and Fall Member Meetings: Bring HTC staff together to connect, share best practices, and learn about key issues impacting HTCs.
  • Continuing Education (CE) Meetings: Bring nurses, pharmacists, physical therapists, and social workers together for discipline-specific continuing education, peer learning, and networking in support of the bleeding disorders community.
  • New HTC Staff Meeting: Brings staff new to their HTC or transitioning into a more operational role together to build knowledge, make connections, and better understand 340B and HTC operations.
  • Medical Providers & Business Administrators (MPBA) Meeting: HTC leaders come together to connect, collaborate, and plan for the future.
  • Member Webinars: Educate our members on HTC operations and organizational management, payer relations, regulations and legal updates, advocacy, and manufacturer updates.


Relevant non-member meetings and events within the bleeding disorder community are also listed here.

🟥 Member Webinar : Hemophilia Alliance Hosts – A Webinar from Sanofi – Translating Evidence into Practice: ​Real-World Patient Cases with ALTUVIIIO

Date: Wednesday, December 3rd, 2025 Time: 2:00pm - 3:00pm ET       WEBINAR TOPIC: Translating Evidence into Practice: ​Real-World Patient Cases with ALTUVIIIO. OBJECTIVE: This session will bring together clinical evidence and real-world experience to illustrate how ALTUVIIIO can optimize treatment and improve outcomes for patients living with Hemophilia A. AUDIENCE: All HTC Staff. Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A Webinar from CSL Behring – New! Real-World Evidence to Support Optimization of Factor IX Prophylaxis

Date: Thursday, December 11th, 2025 Time: 2:00pm - 3:00pm ET         WEBINAR TITLE: New! Real-World Evidence to Support Optimization of Factor IX Prophylaxis SUMMARY: This webinar will discuss recent evidence on prophylactic treatment strategies for hemophilia B from a U.S. real-world retrospective analysis of factor IX products. The session will highlight factor Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A Webinar from CSL Behring – Five-Year Analysis: Efficacy and Safety of HEMGENIX®

Date: Thursday, January 15th, 2026 Time: 1:00pm - 2:00pm ET         WEBINAR TITLE: Five-Year Analysis: Efficacy and Safety of HEMGENIX® SUMMARY: Presentation of the published efficacy and safety results of the five-year analysis of the HOPE-B clinical trial follow up. AUDIENCE: All HTC Staff. SPEAKER: Vidhi Desai, Senior Medical Director (Coagulation), US Read the full article...